|
|
||||||||
Published online before print June 24, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype
Sir William Dunn School of Pathology, South Parks Road, Oxford, United Kingdom
@ To whom correspondence should be addressed. E-mail: Christine.holt{at}path.ox.ac.uk.
| Abstract |
|---|
Innate and adaptive immune activation of macrophages (M
) by microorganisms and antigen-activated lymphoid cells, respectively, plays an important role in host defense and immunopathology. Antigen-presenting cells express a range of pattern recognition receptors including the class A types I and II scavenger receptors (SR-A) and Toll-like receptors (TLR). Recognition of microbial products by SR-A and TLR controls uptake, killing, altered gene expression, and the adaptive immune response; however, the contribution of each receptor and interplay with cytokine stimuli such as interferon-
(IFN-
) are not defined. We used Neisseria meningitidis (NM), a potent activator of innate immunity, and IFN-
, a prototypic T helper cell type 1 proinflammatory cytokine, to compare surface antigens, secretion of mediators, and receptor functions in elicited peritoneal M
from wild-type and genetically modified mouse strains. We show that these stimuli regulate major histocompatibility complex type II (MHC-II) and costimulatory molecules differentially, as well as expression of the mannose receptor and of M
receptor with collagenous structure (MARCO), a distinct SR-A, which provides a selective marker for innate activation. In combination, NM inhibited up-regulation of MHC-II by IFN-
while priming enhanced release of tumor necrosis factor
and nitric oxide. The SR-A contributes to phagocytosis of the organisms but not to their ability to induce CD80, CD86, and MARCO or to inhibit MHC-II. Conversely, studies with lipopolysaccharide (LPS)-deficient organisms and/or TLR-4 mutant mice showed that LPS and TLR-4 are at least partially required to induce CD80, CD86, and MARCO, but LPS is not required to inhibit MHC-II. These studies provide an experimental model and identify surface markers for analysis of innate and acquired immune activation of M
.
Key Words: macrophages cellular activation cell-surface molecules phagocytosis bacterial infection
This article has been cited by other articles:
![]() |
K. Miura, H. Toh, H. Hirakawa, M. Sugii, M. Murata, K. Nakai, K. Tashiro, S. Kuhara, Y. Azuma, and M. Shirai Genome-wide Analysis of Chlamydophila pneumoniae Gene Expression at the Late Stage of Infection DNA Res, April 1, 2008; 15(2): 83 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Okamura, J. M. Lopez-Guisa, K. Koelsch, S. Collins, and A. A. Eddy Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury Am J Physiol Renal Physiol, August 1, 2007; 293(2): F575 - F585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Peiser, K. Makepeace, A. Pluddemann, S. Savino, J. C. Wright, M. Pizza, R. Rappuoli, E. R. Moxon, and S. Gordon Identification of Neisseria meningitidis Nonlipopolysaccharide Ligands for Class A Macrophage Scavenger Receptor by Using a Novel Assay Infect. Immun., September 1, 2006; 74(9): 5191 - 5199. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Greaves and S. Gordon Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors J. Lipid Res., January 1, 2005; 46(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |